Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xintai Medical, a core subsidiary of Lifetech Scientific, is a leading medical device company specializing in structural heart disease treatments. The company is best known for its extensive portfolio of occluders used to treat congenital heart defects such as atrial septal defects (ASD) and ventricular septal defects (VSD). Their product lines, including the Cera and HeartR series, are widely utilized globally for minimally invasive transcatheter repairs. Beyond congenital heart disease, Xintai Medical develops advanced solutions for stroke prevention through left atrial appendage (LAA) closure and peripheral vascular interventions. The company is recognized for its innovation in biocompatible materials, particularly its proprietary ceramic-coated nitinol technology which reduces nickel ion release.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xintai Medical.